Strive compounds tirzepatide — but can you price each step before the consult?

Strive Pharmacy is a direct 503A compounder. Its public medications list includes Tirzepatide/Glycine/B12 for injection and Tirzepatide in SubMagna® as an oral suspension — both formulated with glycine and vitamin B12 for side-effect management per Strive's product pages. Prescribers submit patient-specific orders through Strive's prescriber portal and catalog at catalog.strivepharmacy.com; Strive compounds and ships from its LegitScript-certified facility.

This page covers ordering workflow and economics, not clinical dosing. The titration schedule is a prescriber decision; the platform's job is to make the right formulation reach the patient with a correct SIG and to show what each step costs. What you should evaluate is whether the platform shows per-vial cost at each step before you quote patients, batches a full refill day into one validated cart, and catches errors before payment.

Listing tirzepatide is table stakes. The gaps that matter for a volume cash-pay program are pricing visibility before the consult (Strive's clinic agreement rates are not on the public catalog — one blended quote can hide where a wide-dose protocol loses margin), refill-day workflow (the prescriber portal is built for patient-specific submission rather than batching dozens of protocol refills in one checkout), and validation timing (a wrong vial for the step, a SIG error, or a licensure mismatch is better caught before payment than after a fulfillment rejection).

Fizy Health is the same 503A category but built around those pressure points. Per-vial 503A cost shows on each catalog and cart line before checkout, so you can price each protocol step on a real number. The whole refill day goes into one validated clinic cart. Steady patients can move to auto-ship. Cart validation catches step-vial mismatches, invalid SIGs, and licensure issues before you pay.